metricas
covid
Buscar en
Revista Colombiana de Reumatología
Toda la web
Inicio Revista Colombiana de Reumatología Fibrosis retroperitoneal idiopática: un enigma médico
Información de la revista
Vol. 16. Núm. 4.
Páginas 361-373 (diciembre 2009)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 16. Núm. 4.
Páginas 361-373 (diciembre 2009)
Acceso a texto completo
Fibrosis retroperitoneal idiopática: un enigma médico
Retroperitoneal fibrosis: a medical enigma
Visitas
10865
Publio Giovanni Saavedra Ramírez1, Marcos Arango Barrientos2, Luis Alonso González Naranjo3
1 Médico internista-reumatólogo, Hospital Universitario San Vicente de Paúl, Medellín
2 Médico residente de medicina interna, Universidad de Antioquia-Hospital Universitario San Vicente de Paúl, Medellín
3 Profesor Sección de Reumatología, Hospital Universitario San Vicente de Paúl, Universidad de Antioquia. Medellín, Colombia
Este artículo ha recibido
Información del artículo
Resumen

La fibrosis retroperitoneal es una enfermedad rara de causa desconocida. Fue descrita por primera vez en la literatura inglesa en 1948 por Ormond. Sin embargo, la primera descripción conocida de esta enfermedad fue realizada por el urólogo francés Albarran en 1905. Se caracteriza por una inflamación crónica e inespecífica del retroperitoneo, la cual puede atrapar y obstruir las estructuras que allí se encuentran, particularmente a los uréteres. Es frecuente que la enfermedad se detecte en etapas avanzadas, cuando se manifiesta por falla renal crónica. Los avances en las técnicas imaginológicas y el mayor conocimiento de la entidad han permitido que el diagnóstico se realice con mayor frecuencia en etapas más tempranas, cuando los pacientes aún no se encuentran obstruidos. Como resultado de las observaciones que muestran que los aneurismas inflamatorios de la aorta abdominal difieren de la enfermedad de Ormond sólo en el diámetro de la aorta inflamada, se ha sugerido que ambos síndromes representan variaciones de la misma patología, la cual se ha llamado “periaortitis crónica”.

Palabras clave:
fibrosis retroperitoneal idiopática
enfermedad de Ormond
obstrucción ureteral
periaortitis crónica.
Summary

Retroperitoneal fibrosis is an uncommon disease of unclear cause. It was described for the first time in English literature by Ormond, in 1948. However, the first known description of this disease was done by the French urologist Albarran, around 1905. It is characterized by chronic nonspecific inflammation of the retroperitoneum that can entrap and obstruct retroperitoneal structures, notably the urethers. This disease frequently is detected only after severe renal failure is present. However, advances in imaging techniques and increased awareness of the disease have resulted in an earlier diagnosis in unobstructed patients. As a result of the observations that showed that the only difference between an inflammatory aneurysm of the abdominal aorta and Ormond's disease is the diameter of the vessel, it had been suggested that both syndromes represent variations of the same pathology, which has been named “chronic periaortitis”

Key words:
idiopathic retroperitoneal fibrosis
Ormond's disease
Ureteral obstruction
chronic periaortitis
El Texto completo está disponible en PDF
Referencias
[1.]
J. Albarran.
Retention renale par peri-ureterite: liberation externe de l’uretere.
Assoc Fr Urol, 9 (1905), pp. 511-517
[2.]
J.K. Ormond.
Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process.
J Urol, 59 (1948), pp. 1072-1079
[3.]
L.R.I. Baker.
Auto-allergic periaortitis (Idiopathic Retroperitoneal Fibrosis).
BJU Int, 92 (2003), pp. 663-665
[4.]
M.J. Mitchinson, J.F. Withycombe, R.A. Jones.
The response of idiopathic retroperitoneal fibrosis to corticosteroids.
Br J Urol, 43 (1971), pp. 44-49
[5.]
A. Vaglio, C. Salvarani, C. Buzio.
Retroperitoneal fibrosis.
[6.]
G.S. Gilkeson, N.B. Allen.
Retroperitoneal fibrosis: a true connective tissue disease.
Rheum Dis Clin North Am, 22 (1996), pp. 23-38
[7.]
A. Vaglio, A. Palmisano, D. Corradi, C. Salvarani, C. Buzio.
Retroperitoneal fibrosis: Evolving Concepts.
Rheum Dis Clin N Am, 33 (2007), pp. 803-817
[8.]
L. Koep, G.D. Zuidema.
The clinical significance of retroperitoneal fibrosis.
Surgery, 81 (1977), pp. 250-257
[9.]
D.V. Parums.
The spectrum of chronic periaortitis.
Histopathology, 16 (1990), pp. 423-431
[10.]
M.J. Mitchinson.
Chronic periaortitis and periarteritis.
Histopathology, 8 (1984), pp. 589-600
[11.]
T. Uibu, P. Oksa, A. Auvinen, et al.
Asbestos exposure as a risk factors for retroperitoneal fibrosis.
Lancet, 363 (2004), pp. 1422-1426
[12.]
E.F. van Bommel, I. Jansen, T.R. Hendriksz, A.L. Aarnoudse.
Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation.
Medicine (Baltimore), 88 (2009), pp. 193-201
[13.]
D. Martorana, A. Vaglio, P. Greco, et al.
Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin.
Arthritis Rheum, 55 (2006), pp. 126-130
[14.]
D.V. Parums, D.L. Brown, M.J. Mitchinson.
Serum antibodies to oxidized low-density lipoproteins and ceroid in chronic periaortitis.
Arch Pathol Lab Med, 114 (1990), pp. 383-387
[15.]
A. Vaglio, D. Corradi, L. Manenti, et al.
Evidence of autoimmunity in chronic periaortitis: a prospective study.
Am J Med, 114 (2003), pp. 454-462
[16.]
O.I. Lindell, H.V. Sariola, T.A. Lehtonen.
The occurrence of vasculitis in perianeurysmal retroperitoneal fibrosis.
J Urol, 138 (1987), pp. 727-729
[17.]
K. Warnatz, A.G. Keskin, C. Uhl, et al.
Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature.
Ann Rheum Dis, 64 (2005), pp. 828-833
[18.]
P.J. Scheel Jr., N. Feeley.
Retroperitoneal fibrosis: the clinical, laboratory, and radiographic presentation.
Medicine (Baltimore), 88 (2009), pp. 202-207
[19.]
A.H. Elkind, A.P. Friedman, A. Bachman, et al.
Silent retroperitoneal fibrosis associated with methysergide therapy.
JAMA, 206 (1968), pp. 1041-1044
[20.]
J.J. Kottra, N.R. Dunnick.
Retroperitoneal fibrosis.
Radiol Clin North Am, 43 (1996), pp. 1259-1275
[21.]
S. Ahmad.
Methyldopa and retroperitoneal fibrosis.
Am Heart J, 105 (1983), pp. 1037-1038
[22.]
M. Laakso, I. Arvala, S. Tervonen, M. Sotarauta.
Retroperitoneal fibrosis associated with sotalol.
Br Med J, 285 (1982), pp. 1085-1086
[23.]
V.V. Waters, Hydralazine.
hydrochlorothiazide and ampicillin associated with retroperitoneal fibrosis: case report.
J Urol, 141 (1989), pp. 936-937
[24.]
C.T. Lewis, E.A. Molland, V.R. Marshall, et al.
Analgesic abuse, ureteric obstruction, and retroperitoneal fibrosis.
Br Med J, 2 (1975), pp. 76-78
[25.]
M.H. Thomas, G.D. Chisholm.
Retroperitoneal fibrosis associated with malignant disease.
Br J Cancer, 28 (1973), pp. 453-458
[26.]
M.J. Stower, J.D. Hardcastle.
Malignant retroperitoneal sarcoma: a review of 32 cases.
Clin Oncol, 8 (1982), pp. 257-263
[27.]
S. Chander, E.L. Ergun, H.T. Chugani, et al.
High 2- deoxy-2-[18F]- fluoro-D-glucose accumulation in a case of retroperitoneal fibrosis following resection of carcinoid tumor.
Mol Imaging Biol, 4 (2002), pp. 363-368
[28.]
I.M. Modlin, B.S. Shapiro, M. Kidd.
Carcinoid tumors and fibrosis: an association with no explanation.
Am J Gastroenterol, 99 (2004), pp. 2466-7248
[29.]
A. Seth, M.S. Ansari, V. Trikha, R. Mittal.
Retroperitoneal fibrosis: a rare complication of Pott's disease.
J Urol, 166 (2001), pp. 622-623
[30.]
M.R. Milam, S.J. Schultenover, M. Crispens, L. Parker.
Retroperitoneal fibrosis secondary to actinomycosis with nointrauterine device.
Obstet Gynecol, 104 (2004), pp. 1134-1136
[31.]
M.C. Wilson, A.R. Berry, T.J. McNair, J.W. Thomson.
Obstructive uropathy after pan-proctocolectomy for ulcerative colitis.
Gut, 21 (1980), pp. 808-809
[32.]
J.F. Garcia, E. Sanchez, E. Lloret, et al.
Crystal-storing histiocytosis and immunocytoma associated with multifocal fibrosclerosis.
Histopathology, 33 (1998), pp. 459-464
[33.]
T.P. Glynn Jr., D.L. Kreipke, J.M. Irons.
Amyloidosis: diffuse involvement of the retroperitoneum.
[34.]
J. Serratrice, B. Granel, C. De Roux, et al.
“Coated aorta”: a new sign of Erdheim-Chester disease.
J Rheumatol, 27 (2000), pp. 1550-1553
[35.]
H.J. Hoekstra, C. Restrepo, T.J. Kinsella, W.F. Sindelar.
Histopathological effects of intraoperative radiotherapy on pancreas and adjacent tissues: a postmortem analysis.
J Surg Oncol, 37 (1988), pp. 104-108
[36.]
M. Resnick, E. Kursh.
Extrinsic obstruction of the ureter.
Campbell's Urology, 7th, pp. 403-722
[37.]
L.V. Wagenknecht, J. Auvert.
Symptoms and diagnosis of retroperitoneal fibrosis.
Urol Int, 26 (1971), pp. 185-195
[38.]
H. Lepor, P.C. Walsh.
Idiopathic retroperitoneal fibrosis.
J Urol, 122 (1979), pp. 1-6
[39.]
L.R. Baker, W.J. Mallinson, M.C. Gregory, E.A. Menzies, W.R. Cattell, H.N. Whitfield, W.F. Hendry, J.E. Wickham, A.M. Joekes.
Idiopathic retroperitoneal fibrosis. A retrospective analysis of 60 cases.
Br J Urol, 60 (1987), pp. 497-503
[40.]
R.N. Jois, K. Gaffney, T. Marshall, et al.
Chronic periaortitis.
Rheumatology, 43 (2004), pp. 1441-1446
[41.]
H. Yamada, R. Komatsu, H. Nagae, et al.
Idiopathic retroperitoneal fibrosis with duodenal obstruction successfully treated with corticosteroids.
Intern Med, 37 (1998), pp. 592-598
[42.]
H. Okada, S. Takahira, S. Sugahara, et al.
Retroperitoneal fibrosis and systemic lupus erythematosus.
Nephrol Dial Transplant, 14 (1999), pp. 1300-1302
[43.]
C.P. Mavragani, M. Voulgarelis.
Retroperitoneal fibrosis and c-ANCA positivity.
Clin Rheumatol, 26 (2007), pp. 115-116
[44.]
M. Armigliato, R. Paolini, E. Bianchini, et al.
Hashimoto's thyroiditis and Graves’ disease associated with retroperitoneal fibrosis.
Thyroid, 12 (2002), pp. 829-831
[45.]
R.M. Saldino, A.J. Palubinskas.
Medial placement of the ureter: a normal variant, which may simulate retroperitoneal fibrosis.
J Urol, 107 (1972), pp. 582-585
[46.]
I. Vivas, A.I. Nicolas, P. Velásquez, et al.
Retroperitoneal fibrosis: typical and atypical manifestations.
Br j Radiol, 73 (2000), pp. 214-222
[47.]
M. Nakajo, S. Jinnouchi, H. Tanabe, et al.
18FFluorodeoxyglucose Positron Emission Tomography Features of Idiophatic Retroperitoneal Fibrosis.
J Comput Assist Tomogr, 31 (2007), pp. 539-543
[48.]
R.E. Petras.
Nonneoplastic intestinal diseases.
Sternberg's diagnostic surgical pathology,, 4th, pp. 1475-1542
[49.]
C.M. Coffin, J. Watterson, J.R. Priest, L.P. Dehner.
Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor): a clinicopathologic and immunohistochemical study of 84 cases.
Am J Surg Pathol, 19 (1995), pp. 859-872
[50.]
D.V. Parums, D.R. Chadwick, M.J. Mitchinson.
The localization of immunoglobulin in chronic periaortitis.
Atherosclerosis, 61 (1986), pp. 117-123
[51.]
C. Ilie, R. Pemberton, D. Tolley.
Idiopathic retroperitoneal fibrosis: the case for nonsurgical treatment.
[52.]
R. Marcolongo, I.M. Tavolini, F. Laveder, et al.
Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases.
Am J Med, 116 (2004), pp. 194-197
[53.]
E.F. van Bommel, C. Siemes, L.E. Hak, et al.
Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone.
Am J Kidney Dis, 49 (2007), pp. 615-625
Copyright © 2009. Asociación Colombiana de Reumatología
Descargar PDF
Opciones de artículo